Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
864.25
0.80 (0.09%)
< Home < Back

Cadila Healthcare loses Prevacid SoluTab patent infringement case v/s Takeda: Report

Date: 09-05-2013

Cadila Healthcare has reportedly lost Prevacid SoluTab patent infringement case against Takeda after New Jersey court ruled in Takeda’s favour in case of Lansoprazole ODT. Prevacid SoluTab is used to treat gastric ulcers. Earlier, Takeda had sued Cadila Healthcare on filing for generic ODT.

Cadila Healthcare focuses on various areas, such as formulations (human and veterinary), new drug discovery, novel drug delivery, pharmaceutical ingredients, analytical research, phytochemistry, biotechnology, plant tissue culture, etc.